EUTOPS postdoctoral researcher Chiara Herzog receives the Ernst Brandl Prize

EUTOPS postdoctoral researcher Chiara Herzog has received the Ernst Brandl Prize of €4,000 for her work on the development and validation of a novel epigenetic test – the WID-qEC test – for the early detection of endometrial cancer. Chiara is an integral member of the EUTOPS team, working on computational aspects of epigenetics in cancer development and prevention and in ageing research.

A new molecular test captures Human Papilloma Virus (HPV) induced changes in a woman’s epigenome

A new publication from Professor Martin Widschwendter and the EUTOPS team in the International Journal of Cancer describes the development of cervical cancer as a result of Human Papilloma Virus (HPV) infection.

Women’s cancer detection and risk prediction – four cancers, one test

The EUTOPS team presents four publications demonstrating that DNA methylation signature assessment using methylation array analysis in cervical screening samples detects and likely predicts the risk for all four major women’s cancers: breast, ovarian, womb and cervical cancer.

New cervical screening test could predict cell changes years before they happen

A new publication from Professor Martin Widschwendter and the EUTOPS team in Genome Medicine describes a new molecular test that can identify 55% of those with a normal cervical smear result who will go on to develop advanced cell changes or cancer within 4 years.


With the LIFE and SUN Tyrol studies, we are launching two large-scale investigations to test interval fasting, exercise and stress reduction for their health-promoting effects (LIFE Tyrol) and to optimize smoking cessation (SUN Tyrol).

New molecular test proves reliable for early detection of womb cancer

Our paper describing a new test that accurately identifies women with womb cancer appears in Journal of Clinical Oncology today.

Breast cancer prevention with antiprogestins and the WID-Breast29 index

Our paper describing individualised breast cancer prevention and risk monitoring using antiprogestins and the epigenetic WID-Breast29 index appears in Genome Medicine today.

Publication of WID epigenetic clocks

Today we published the WID epigenetic clocks (WID-age and WID-relative epithelial age, WID-REA) in Genome Biology.

Publication of WID Tests

Two new papers, assessing the risk for breast and ovarian cancer using the epigenetic footprint of cervical screening samples (WID Tests), are published in Nature Communications today.

Group member Chiara Herzog wins Falling Walls Lab Austria

Chiara Herzog, postdoctoral researcher at the EUTOPS Institute, has won the Falling Walls Lab Austria competition.

EUTOPS Institute

Our vision is to integrate cutting-edge research in systems biology and oncology to enable real-world implementation of the concepts of P4 medicine (predictive, preventive, personalised and participatory) and drastically reduce cancer mortality.

Meet the Team

We are a dynamic and international team with wide range of expertise.